Surveillance of Fungal Infections During Construction Activity

This study has been completed.

First Received on May 14, 2007. Last Updated on May 19, 2011 History of Changes

Sponsor:	University Hospital Inselspital, Berne
Information provided by:	University Hospital Inselspital, Berne
ClinicalTrials.gov Identifier:	NCT00473252

Purpose

Fungal infections in immunocompromised patients occuring during construction activities in hospitals have repeatedly been reported.

However, the question of a causal relation between construction activities and infections has never been addressed systematically and prospectively.

To answer this question, we will monitor our immunosuppressed patients' health status, as well as fine dust and aspergillus spore contents in the air during a three year construction activity period in our hospital.

Condition
Aspergillosis

Study Type:	Observational
Study Design:	Observational Model: Cohort Time Perspective: Prospective

Resource links provided by NLM:

MedlinePlus related topics: Aspergillosis Fungal Infections Kidney Transplantation Molds

U.S. FDA Resources

Further study details as provided by University Hospital Inselspital, Berne:

Enrollment:	340
Study Start Date:	May 2006
Study Completion Date:	July 2009
Primary Completion Date:	July 2009 (Final data collection date for primary outcome measure)

Groups/Cohorts
Hemodialysis patients
Renal transplant patients

Eligibility

Ages Eligible for Study:	16 Years and older
Genders Eligible for Study:	Both
Accepts Healthy Volunteers:	No
Sampling Method:	Probability Sample

Study Population

Prevalent hemodialysis patients and incident renal transplant recipients in the Department of Nephrology and Hypertension, University Hospital Bern, Switzerland

Criteria

Inclusion Criteria:

Kidney transplantation
Chronic hemodialysis treatment

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00473252

Locations

Switzerland
Dept. Nephrology & Hypertension, Univ. Hospital Bern
Bern, Switzerland, 3010

Sponsors and Collaborators

University Hospital Inselspital, Berne

Investigators

Study Director:

Andreas Pasch, MD

University of Bern

More Information

No publications provided

Responsible Party:	Andreas Pasch, Department of Nephrology and Hypertension, Inselspital, University Hospital Bern
ClinicalTrials.gov Identifier:	NCT00473252 History of Changes
Other Study ID Numbers:	BE003
Study First Received:	May 14, 2007
Last Updated:	May 19, 2011
Health Authority:	Switzerland: Ethikkommission

Keywords provided by University Hospital Inselspital, Berne:

aspergillus infections
immunosuppression
kidney transplantation
hemodialysis

galactomannan test
fine dust
construction activity
airborne aspergillus spores

Additional relevant MeSH terms:

Aspergillosis
Mycoses

ClinicalTrials.gov processed this record on February 12, 2012